Coronavirus Update: UK Calls For COVID-19 Patients To Join Trials
Reflects Global COVID-19 Trial Recruitment Challenge
Executive Summary
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.